D'Incalci M.

Type de document

Co-auteur

D. Yarosh

R. Vazquez

F. Shen

M.E. Riveiro

A. Rinaldi

K. Rezai

E. Raymond

L. Perey

E. Odore

K. Noel

C. Marzolini

D. Liénard

S. Leyvraz

F. Lejeune

I. Kwee

G. Inghirami

M. Gander

R. Frapolli

L. Decosterd

E. Cvitkovic

G. Colella

M. Bonfanti

J. Biollaz

F. Bertoni

M. Belanich

M. Bekradda

L. Astorgues-Xerri

Date

Source

Serveur académique Lausannois (2)

Mot-clé

thérapie (2) protéine (2) Treatment (2) Tumors (2) Therapeutics (2) Patients (2) Human beings (2) Cells (2) Patients (2) administration (1) tumeur (1) toxicité (1) itinéraire (1) pharmacocinétique (1) association (1) modèle (1) gène (1) exposition (1) dose (1) ligne (1) adulte (1) Dose-response relationship (1) Chemotherapy (1) Control (1) Inhibitors (1) Methods (1) Derivatives (1) Cases (1) Genes (1) Small cell lung cancer (1)

Documents écrit par D'Incalci M. (2) | parle de D'Incalci M. (0)

OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations.

M.E. Riveiro et al. (20 déc. 2016)

Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours

M. Gander et al.